BIOMAT Database Logo BIOMAT Database Logo

[Difficulties in research on antibodies to HTLV-I]. 1989

V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz

UI MeSH Term Description Entries
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Antibodies to HTLV-I in Japanese immigrants in Brazil.
November 1986, JAMA,
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
HTLV-I antibodies in childhood leukemia.
May 1985, JAMA,
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Polymyositis and HTLV-I antibodies.
March 1989, Annals of neurology,
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Serum antibodies to HTLV-I in human demyelinating disease.
April 1987, Acta neurologica Scandinavica,
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
Chemiluminescence immunoassay to detect anti-HTLV-I antibodies.
August 1993, Japanese journal of cancer research : Gann,
V Soriano, and J Tor, and A Ribera, and M Pauplana, and R Muga, and B Clotet, and M Foz
LAV/HTLV-III and HTLV-I antibodies in hemodialysis patients.
January 1986, Nephron,
Copied contents to your clipboard!